FDA Extends the UDI Compliance Date for Certain Class I and Unclassified Devices

UpdateWith the deadline for compliance with the unique device identification system[i] (UDI system) requirements for certain Cass I and unclassified devices other than implantable, life-supporting, or life-sustaining devices (i.e., lower risk devices) over 3 years away (September 24, 2020), the Food and Drug Administration (FDA or agency) issued a letter on June 2, 2017, expressing its intend to extend the compliance date for these types of medical devices until September 24, 2022. In the letter, the FDA acknowledged that there have been some challenges associated with the implementation of the UDI requirements.

Specifically, the agency noted that

after fully considering the time needed to meet UDI requirements, many labelers asked FDA for extensions to comply. In addition, [the agency] identified complex policy and technical issues that need resolution such as how UDI applies to products such as medical procedure trays that contain implantable devices and instruments.  Providing accurate and timely support to labelers has also been challenging due to the sheer number and wide diversity of devices.

In addition to these concerns, FDA noted that in order to “fully reap the public health benefits and a return on investment of a UDI system, high quality UDI data must be available in standardized ways so that the health care community can and will use it with confidence.”

FDA plans to issue a guidance document outlining an enforcement discretion[ii] policy for labeling Global Unique Device Identification Database (GUDID) data submission, standard date formatting, and direct marking requirements for class I and unclassified devices as indicated in the table below.  The agency did not provide a date for when this guidance document will be available to the public and regulated community.

Type of Device Label (21 CFR 801.20), GUDID Submission (21 CFR Part 830, subpart E), and Standard Date Format (21 CFR 801.18) Requirements Direct Mark (21 CFR 801.45) Requirements

Class I devices[iii] September 24, 2020 September 24, 2022
Unclassified devices September 24, 2020 September 24, 2022

[i] The FDA published a Final Rule establishing a UDI system designed to allow adequate identification of devices throughout distribution and use on September 24, 2013.

[ii] Enforcement discretion will not apply to class I or unclassified implantable, life supporting or life-sustaining devices because labelers of these types of devices must already be in compliance with the UDI requirements.

[iii] Class I CGMP-exempt devices are excepted from the UDI requirements per 21 CFR 801.30(a)(2).

Latest Thinking

View more Insights
Insights Center
Knowledge assets are defined in the study as confidential information critical to the development, performance and marketing of a company’s core business, other than personal information that would trigger notice requirements under law. For example,
The new study shows dramatic increases in threats and awareness of threats to these “crown jewels,” as well as dramatic improvements in addressing those threats by the highest performing organizations. Awareness of the risk to knowledge assets increased as more respondents acknowledged that their